Extract from the Register of European Patents

EP About this file: EP0765392

EP0765392 - INTERLEUKIN-5 SPECIFIC RECOMBINANT ANTIBODIES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.02.2005
Database last updated on 19.03.2026
Most recent event   Tooltip04.01.2008Lapse of the patent in a contracting state
New state(s): IT, PT
published on 06.02.2008  [2008/06]
Applicant(s)For all designated states
CELLTECH THERAPEUTICS LIMITED
208 Bath Road Slough
Berkshire SL1 3WE / GB
[N/P]
Former [2004/16]For all designated states
CELLTECH THERAPEUTICS LIMITED
208 Bath Road
Slough, Berkshire SL1 3WE / GB
Former [1997/14]For all designated states
CELLTECH THERAPEUTICS LIMITED
216 Bath Road
Slough, Berkshire SL1 4EN / GB
Inventor(s)01 / EMTAGE, John, Spencer
216 Bath Road
Slough Berkshire SL1 4EN / GB
02 / BODMER, Mark, William
216 Bath Road
Slough Berkshire SL1 4EN / GB
03 / ATHWAL, Diljeet, Singh
216 Bath Road
SLough Berkshire SL1 4EN / GB
[1997/14]
Representative(s)Mercer, Christopher Paul
Carpmaels & Ransford LLP
One Southampton Row
London
WC1B 5HA / GB
[N/P]
Former [1997/14]Mercer, Christopher Paul
Carpmaels & Ransford 43, Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date95921931.216.06.1995
[1997/14]
WO1995GB01411
Priority number, dateGB1994001223017.06.1994         Original published format: GB 9412230
[1997/14]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9535375
Date:28.12.1995
Language:EN
[1995/55]
Type: A1 Application with search report 
No.:EP0765392
Date:02.04.1997
Language:EN
The application published by WIPO in one of the EPO official languages on 28.12.1995 takes the place of the publication of the European patent application.
[1997/14]
Type: B1 Patent specification 
No.:EP0765392
Date:14.04.2004
Language:EN
[2004/16]
Search report(s)International search report - published on:EP28.12.1995
ClassificationIPC:C12N15/13, C07K16/24, C12N15/85, C12N5/10, G01N33/577, A61K39/395
[1997/14]
CPC:
C07K16/244 (EP,US); A61P11/00 (EP); A61P11/06 (EP);
A61P37/02 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P7/00 (EP); A61K38/00 (EP,US); C07K2319/00 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/14]
TitleGerman:INTERLEUKIN-5-SPEZIFISCHE REKOMBINANTE ANTIKÖRPER[1997/14]
English:INTERLEUKIN-5 SPECIFIC RECOMBINANT ANTIBODIES[1997/14]
French:ANTICORPS DE RECOMBINAISON SPECIFIQUES CONTRE L'INTERLEUKINE-5[1997/14]
Entry into regional phase26.11.1996National basic fee paid 
26.11.1996Designation fee(s) paid 
26.11.1996Examination fee paid 
Examination procedure11.01.1996Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.11.1996Examination requested  [1997/14]
02.06.2000Despatch of a communication from the examining division (Time limit: M06)
26.03.2001Reply to a communication from the examining division
08.08.2001Despatch of a communication from the examining division (Time limit: M06)
31.05.2002Reply to a communication from the examining division
24.07.2002Despatch of a communication from the examining division (Time limit: M06)
31.01.2003Reply to a communication from the examining division
11.03.2003Communication of intention to grant the patent
24.10.2003Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
23.12.2003Fee for grant paid
23.12.2003Fee for publishing/printing paid
Opposition(s)17.01.2005No opposition filed within time limit [2005/14]
Request for further processing for:21.01.2004Request for further processing filed
21.01.2004Full payment received (date of receipt of payment)
Request granted
27.02.2004Decision despatched
31.05.2002Request for further processing filed
31.05.2002Full payment received (date of receipt of payment)
Request granted
27.06.2002Decision despatched
26.03.2001Request for further processing filed
26.03.2001Full payment received (date of receipt of payment)
Request granted
20.04.2001Decision despatched
Fees paidRenewal fee
26.11.1996Renewal fee patent year 03
15.06.1998Renewal fee patent year 04
14.06.1999Renewal fee patent year 05
13.06.2000Renewal fee patent year 06
13.06.2001Renewal fee patent year 07
12.06.2002Renewal fee patent year 08
12.06.2003Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT14.04.2004
IT14.04.2004
NL14.04.2004
IE16.06.2004
LU16.06.2004
MC30.06.2004
DK14.07.2004
GR14.07.2004
SE14.07.2004
PT14.09.2004
[2008/06]
Former [2006/13]AT14.04.2004
NL14.04.2004
IE16.06.2004
LU16.06.2004
MC30.06.2004
DK14.07.2004
GR14.07.2004
SE14.07.2004
Former [2005/24]AT14.04.2004
IE16.06.2004
LU16.06.2004
MC30.06.2004
DK14.07.2004
GR14.07.2004
SE14.07.2004
Former [2005/23]AT14.04.2004
LU16.06.2004
MC30.06.2004
DK14.07.2004
GR14.07.2004
SE14.07.2004
Former [2005/18]AT14.04.2004
MC30.06.2004
DK14.07.2004
GR14.07.2004
SE14.07.2004
Former [2005/11]AT14.04.2004
MC30.06.2004
GR14.07.2004
SE14.07.2004
Former [2005/06]GR14.07.2004
SE14.07.2004
Former [2004/52]SE14.07.2004
Cited inInternational search[Y]   J. DENBURG ET AL.: "Interleukin-5 is a human basophilopoietin: Induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors.", BLOOD, vol. 77, no. 7, 1 April 1991 (1991-04-01), NEW YORK, NY, USA, pages 1462 - 1468 [Y] 1-18 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.